Lab
Salud Integral En LA Montana, INC
Salud Integral En LA Montana, INC was paid $244K by Medicaid between Jan 2019 and Dec 2024, across 56 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 11% of everything it billed.
33Billing provider infoSALUD INTEGRAL EN LA MONTANA, INC
BARRANQUITAS, PR 00794
BARRANQUITAS, PR 00794
33aNPI1013412766assigned 03/26/2018
33bProvider typeClinical Medical Laboratory
28Total paid$244K
24GClaims135,343
24DCodes billed56
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#417 of 777
Median peer was paid$278K
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 16,365 | $12K | |
| 2020 | 19,032 | $46K | |
| 2021 | 24,970 | $39K | |
| 2022 | 23,390 | $45K | |
| 2023 | 27,044 | $43K | |
| 2024incomplete | 24,542 | $59K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 11% | 1,945 | 1,668 | $27K |
| 84443 | Thyroid stimulating hormone (TSH) | 9.4% | 11,550 | 10,938 | $23K |
| 80061 | Lipid panel | 8.3% | 13,015 | 12,318 | $20K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.8% | 3,725 | 3,533 | $19K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.6% | 16,342 | 15,282 | $16K |
| 80053 | Comprehensive metabolic panel | 6.5% | 12,876 | 12,141 | $16K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.8% | 2,425 | 2,271 | $14K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.6% | 1,427 | 1,325 | $14K |
| 80074 | 4.9% | 1,289 | 1,204 | $12K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.4% | 4,323 | 4,094 | $11K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.1% | 1,190 | 1,082 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.5% | 8,481 | 8,008 | $9K |
44 more codes
| 82274 | 3.5% | 5,324 | $9K | |
| 86703 | 3.4% | 4,776 | $8K | |
| 81000 | 2.4% | 14,534 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 3,159 | $3K |
| 84153 | 1.1% | 1,111 | $3K | |
| 86592 | 1.0% | 3,987 | $3K | |
| 82043 | <1% | 4,048 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 138 | $2K |
| 86803 | <1% | 1,285 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,087 | $2K |
| 86738 | <1% | 685 | $2K | |
| 82570 | <1% | 2,994 | $2K | |
| 84439 | <1% | 1,057 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 682 | $2K |
| 82607 | <1% | 763 | $1K | |
| 84154 | <1% | 451 | $839.02 | |
| 80050 | General health panel | <1% | 4,091 | $710.61 |
| 85730 | <1% | 588 | $547.06 | |
| 82728 | <1% | 333 | $502.24 | |
| 85610 | <1% | 632 | $393.46 | |
| 80069 | <1% | 558 | $381.43 | |
| 86800 | <1% | 112 | $348.32 | |
| 85651 | <1% | 492 | $287.70 | |
| 82746 | <1% | 250 | $270.73 | |
| 83970 | <1% | 57 | $243.86 | |
| 82947 | <1% | 706 | $195.33 | |
| 83540 | <1% | 313 | $125.30 | |
| 83550 | <1% | 273 | $111.98 | |
| 83655 | <1% | 109 | $95.62 | |
| 84550 | <1% | 95 | $85.16 | |
| 86038 | <1% | 51 | $83.44 | |
| 82950 | <1% | 121 | $80.11 | |
| 84146 | <1% | 27 | $77.46 | |
| 86580 | <1% | 94 | $77.17 | |
| 82044 | <1% | 307 | $75.17 | |
| 84460 | <1% | 157 | $73.22 | |
| 84450 | <1% | 131 | $61.88 | |
| 86140 | <1% | 49 | $53.12 | |
| 84703 | <1% | 24 | $36.40 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12 | $20.00 |
| 82952 | <1% | 36 | $10.17 | |
| 87177 | <1% | 24 | $7.69 | |
| 82042 | 0% | 15 | $0.00 | |
| 82747 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAMADOR, GLORIA (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Salud Integral En LA Montana, INC | Naranjito, PR | $1.29M |
| Salud Integral En LA Montana, INC. | Barranquitas, PR | $1.01M |
| Salud Integral En LA Montana, INC | Orocovis, PR | $939K |
| Salud Integral En LA Montana, INC | Corozal, PR | $476K |
| Salud Integral En LA Montana, INC | Bayamon, PR | $258K |
| Salud Integral En LA Montana, INC | Naranjito, PR | $14K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.